A review of stimuli-responsive nanocarriers for drug and gene delivery

Journal of Controlled Release

Volumn 126, Issue 3, 2008, Pages 187-204

  Ganta, Srinivas ^a   Devalapally, Harikrishna ^a   Shahiwala, Aliasgar ^a   Amiji, Mansoor ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Nanotechnology; pH; Redox potential; Stimuli responsive nanocarriers; Targeted delivery; Temperature

Indexed keywords

DISEASES; GENE EXPRESSION; NANOTECHNOLOGY;

NANOCARRIER SYSTEMS; STIMULI-RESPONSIVE PROPERTY; TARGETED DELIVERY;

DRUG DELIVERY;

ADALIMUMAB; ANTHRACYCLINE ANTIBIOTIC AGENT; CERAMIDE; CHLORAMBUCIL; DAUNORUBICIN; DOXORUBICIN; INSULIN; MACROGOL; MASTOPARAN; NANOCARRIER; PACLITAXEL; PLASMID DNA; POLYMER; SMALL INTERFERING RNA; TRASTUZUMAB; VASCULOTROPIN RECEPTOR 1;

CANCER MODEL; CHEMICAL STRUCTURE; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; GENE TARGETING; HUMAN; HYPOXIA; MICELLE; NANOTECHNOLOGY; NEOPLASM; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PH; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; TEMPERATURE;

ANIMALS; DRUG CARRIERS; GENE TRANSFER TECHNIQUES; HUMANS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; NANOPARTICLES; OXIDATION-REDUCTION; PHARMACEUTICAL PREPARATIONS; TEMPERATURE;

EID: 39649120532     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.12.017     Document Type: Review

References (168)

1. Couvreur P., and Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharm. Res. 23 7 (2006) 1417-1450
2. Torchilin V.P. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J. 9 (2007) 128-147
3. Moghimi S.M., Hunter A.C., and Murray J.C. Nanomedicine: current status and future prospects. FASEB J. 19 3 (2005) 311-330
4. Torchilin V.P. Multifunctional nanocarriers. Adv. Drug Deliv. Rev. 58 14 (2006) 1532-1555
5. Shenoy D., Little S., Langer R., and Amiji M. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies. Pharm. Res. 22 12 (2005) 2107
6. Shenoy D., Little S., Langer R., and Amiji M. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. in vitro evaluations. Mol. Pharmacol. 2 5 (2005) 357-366
7. Shenoy D.B., and Amiji M.M. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int. J. Pharm. 293 1-2 (2005) 261-270
8. Kommareddy S., and Amiji M. Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione. Bioconjug. Chem. 16 6 (2005) 1423-1432
9. Vaupel P., Kallinowski F., and Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49 23 (1989) 6449-6465
10. Meyer D.E., Shin B.C., Kong G.A., Dewhirst M.W., and Chilkoti A. Drug targeting using thermally responsive polymers and local hyperthermia. J. Control. Release 74 (2001) 213-224
11. Saito G., Swanson J.A., and Lee K.D. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv. Drug Deliv. Rev. 55 2 (2003) 199-215
12. Arrueboa M., Fernández-Pachecoa R., Ibarraa M.R., and Santamaría J. Magnetic nanoparticles for drug delivery. Nano Today 2 3 (2007) 22-32
13. Gould P. Nanomagnetism shows in vivo potential. Nano Today 1 4 (2006) 34-39
14. Ito A., Shinkai M., Honda H., and Kobayashi T. Medical application of functionalized magnetic nanoparticles. J. Biosci. Bioeng. 100 (2005) 1-11
15. Rapoport N. Combined Cancer Therapy by Micellar Encapsulated Drug and Ultrasound (2006), CRC Press, Boca Raton, FL
16. Rapoport N., Marin A., and Christensen D. Ultrasound-activated drug delivery. Drug Deliv. Syst. Sci. 2 (2002) 37-46
17. Gao Z., Fain H., and Rapoport N. Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J. Control. Release 102 (2005) 203-221
18. Rapoport N. Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Prog. Polym. Sci. 32 (2007) 962-990
19. Maeda H., and Matsumura Y. Tumouritropic and lymphotropic principles of macromolecular drugs. Crit. Rev. Ther. Drug Carrier Syst. 6 (1989) 193-210
20. Ohtsuka N., Konno T., Miyauchi Y., and Maeda H. Anticancer effects of arterial administration of the anticancer agent SMANCS with lipiodol on metastatic lymph nodes. Cancer 59 9 (1987) 1560-1565
21. van Vlerken L.E., Duan Z., Seiden M.V., and Amiji M.M. Modulation of Intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer. Cancer Res. 67 10 (2007) 4843-4850
22. Allen T.M., and Cullis P.R. Drug delivery systems: entering the mainstream. Science 303 (2004) 1818-1822
23. Davis S.S. Biomedical applications of nanotechnology - implications for drug targeting and gene therapy. Trends Biotechnol. 15 6 (1997) 217-224
24. Devalapally H., Duan Z., Seiden M.V., and Amiji M.M. Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer. Int. J. Cancer 121 8 (2007) 1830-1838
25. Kommareddy S., Tiwari S.B., and Amiji M.M. Long-circulating polymeric nanovectors for tumor-selective gene delivery. Technol. Cancer Res. Treat. 4 6 (2005) 615-625
26. Kaul G., and Amiji M. Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery. Pharm. Res. 19 7 (2002) 1061-1067
27. Kaul G., and Amiji M. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharm. Res. 22 6 (2005) 951-961
28. Kaul G., and Amiji M. Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles. J. Pharm. Sci. 94 1 (2005) 184-298
29. Kommareddy S., and Amiji M. Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery. Nanomed. 3 1 (2007) 32-42
30. Wagner E. Programmed drug delivery: nanosystems for tumor targeting. Expert. Opin. Biol. Ther. 7 5 (2007) 587-593
31. Sergeeva A., Kolonin M.G., Molldrem J.J., Pasqualini R., and Arap W. Display technologies: application for the discovery of drug and gene delivery agents. Adv. Drug Deliv. Rev. 58 15 (2006) 1622-1654
32. Schluesener H.J., and Xianglin T. Selection of recombinant phages binding to pathological endothelial and tumor cells of rat glioblastoma by in-vivo display. J. Neurol. Sci. 224 1-2 (2004) 77-82
33. Bongartz T., Sutton A.J., Sweeting M.J., Buchan I., Matteson E.L., and Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295 (2006) 2275-2285
34. Farokhzad O.C., Karp J.M., and Langer R. Nanoparticle-aptamer bioconjugates for cancer targeting. Expert. Opin. Drug. Deliv. 3 3 (2006) 311-324
35. Kirpotin D.B., Drummond D.C., Shao Y., Shalaby M.R., Hong K., Nielsen U.B., Marks J.D., Benz C.C., and Park J.W. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res. 66 13 (2006) 6732-6740
36. Elbayoumi T.A., Pabba S., Roby A., and Torchilin V.P. Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents. J. Liposome Res. 17 1 (2007) 1-14
37. Gupta B., and Torchilin V.P. Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice. Cancer Immunol. Immunother. (2007) 1215-1223
38. Sahoo S.K., and Labhasetwar V. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol. Pharm. 2 5 (2005) 373-378
39. Blessing T., Kursa M., Holzhauser R., Kircheis R., and Wagner E. Different strategies for formation of PEGylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjug. Chem. 12 (2001) 529-537
40. Leiden J. Gene therapy - promise, pitfalls, and prognosis. N. Engl. J. Med. 333 (1995) 871-873
41. Oishi M., and Nagasaki Y. Synthesis, characterization, and biomedical applications of core-shell-type stimuli-responsive nanogels - nanogel composed of poly[2-(N,N-diethylamino)ethyl methacrylate] core and PEG tethered chains. React. Funct. Polym. 67 11 (2007) 1311-1329
42. Torchilin V.P. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu. Rev. Biomed. Eng. 8 (2006) 343-375
43. Kichler A., Leborgne C., Coeytaux E., and Danos O. Polyethylenimine-mediated gene delivery: a mechanistic study. J. Gene Med. 3 (2001) 135-144
44. Ogris M., and Wagner E. Targeting tumors with non-viral gene delivery systems. Drug Discov. Today 7 (2002) 479-485
45. Gupta B., and Torchilin V.P. Transactivating transcriptional activator-mediated drug delivery. Expert. Opin. Drug Deliv. 3 2 (2006) 177-190
46. Snyder E.L., and Dowdy S.F. Protein/peptide transduction domains: potential to deliver large DNA molecules into cells. Curr. Opin. Mol. Ther. 3 2 (2001) 147-152
47. Lundberg M., Wikstrom S., and Johansson M. Cell surface adherence and endocytosis of protein transduction domains. Mol. Ther. 8 (2003) 143-150
48. Weissig V., and Torchilin V.P. Drug and DNA delivery to mitochondria. Adv. Drug Deliv. Rev. 49 (2001) 1-2
49. Gerweck L.E., and Seetharaman K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res. 56 6 (1996) 1194-1198
50. Hunt C.A., MacGregor R.D., and Siegal R.A. Engineering targeted In vivo drug delivery I. The physiological & physicochemical principles governing opportunities & limitations. Pharm. Res. 3 (1986) 333-344
51. Bolot G., David M.J., Taki T., Handa S., Kasama T., Richard M., Pignat J.C., Thomas L., and Portoukalian J. Analysis of glycosphingolipids of human head and neck carcinomas with comparison to normal tissue. Biochem. Mol. Biol. Int. 46 1 (1998) 125-135
52. Gal D., MacDonald P.C., Porter J.C., and Simpson E.R. Cholesterol metabolism in cancer cells in monolayer culture. III. Low-density lipoprotein metabolism. Int. J. Cancer 28 3 (1981) 315-319
53. Wike-Hooley J.L., Haveman J., and Reinhold H.S. The relevance of tumour pH to the treatment of malignant disease. Radiother. Oncol. 2 4 (1984) 343-366
54. Dewhirst M.W., Vujaskovic Z., Jones E., and Thrall D. Re-setting the biologic rationale for thermal therapy Int. J. Hyperth. 21 (2005) 779-790
55. Jin H., and Kang K.A. Application of novel metal nanoparticles as optical/thermal agents in optical mammography and hyperthermic treatment for breast cancer. Adv. Exp. Med. Biol. 599 (2007) 45-52
56. Gupta A.K., Naregalkar R.R., Vaidya V.D., and Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomed. 2 1 (2007) 23-39
57. Ahmed M., Lukyanov A.N., Torchilin V., Tournier H., Schneider A.N., and Goldberg S.N. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time. J. Vasc. Interv. Radiol. 16 10 (2005) 1365-1371
58. Ponce A.M., Vujaskovic Z., Yuan F., Needham D., and Dewhirst M.W. Hyperthermia mediated liposomal drug delivery. Int. J. Hyperthon. 22 3 (2006) 205-213
59. Mahato R.I., and Kim S.W. Pharmaceutical Perspectives of Nucleic Acid-Based Therapeutics (2002), Taylor and Francis, London
60. Oupicky D., Carlisle R.C., and Seymour L.W. Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo. Gene Ther. 8 (2001) 713-724
61. Schafer F.Q., and Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30 (2001) 1191-1212
62. Collins D.S., Unanue E.R., and Harding C.V. Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J. Immunol. 147 12 (1991) 4054-4059
63. Meister A., and Anderson M.E. Glutathione. Annu. Rev. Biochem. 52 (1983) 711-760
64. Neu M., Germershaus O., Mao S., Voigt K.-H., Behe M., and Kissel T. Crosslinked nanocarriers based upon poly(ethylene imine) for systemic plasmid delivery: In vitro characterization and in vivo studies in mice. J. Control. Release 118 (2007) 370-380
65. Shim W.S., Kim J.H., Kim K., Kim Y.S., Park R.W., Kim I.S., Kwon I.C., and Lee D.S. pH- and temperature-sensitive, injectable, biodegradable block copolymer hydrogels as carriers for paclitaxel. Int. J. Pharm. 331 1 (2007) 11-18
66. Kim Y.H., Bae Y.H., and Kim S.W. pH/temperature-sensitive polymers for macromolecular drug loading and release. J. Control. Release 28 1-3 (1994) 143-152
67. Benns J.M., Choi J.S., Mahato R.I., Park J.S., and Kim S.W. pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(l-histidine)-graft-poly(l-lysine) comb shaped polymer. Bioconjug. Chem. 11 5 (2000) 637-645
68. Dufresne M.H., Garrec D.L., Sant V., Leroux J.C., and Ranger M. Preparation and characterization of water-soluble pH-sensitive nanocarriers for drug delivery. Int. J. Pharm 277 1-2 (2004) 81-90
69. Bae Y., Nishiyama N., Fukushima S., Koyama H., Yasuhiro M., and Kataoka K. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug. Chem. 16 (2005) 122-130
70. Bae Y., Jang W.D., Nishiyama N., Fukushimaa S., and Kataoka K. Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol. Bio. Syst. 1 (2005) 242-250
71. Liua S.Q., Wiradharma N., Gao S.J., Tong Y.W., and Yang Y.Y. Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs. Biomaterials 28 (2007) 1423-1433
72. Lee E.S., Na K., and Bae Y.H. Polymeric micelle for tumor pH and folate-mediated targeting. J. Control. Release 91 1-2 (2003) 103-113
73. Ishida T., Kirchmeier M.J., Moase E.H., Zalipsky S., and Allen T.M. Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells. Biochim. Biophys. Acta 1515 (2001) 144-158
74. Shigeta K., Kawakami S., Higuchi Y., Okuda T., Yagi H., Yamashita F., and Hashida M. Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells. J. Control. Release 118 2 (2007) 262-270
75. Yamada Y., Shinohara Y., Kakudo T., Chaki S., Futaki S., Kamiya H., and Harashima H. Mitochondrial delivery of mastoparan with transferrin liposomes equipped with a pH-sensitive fusogenic peptide for selective cancer therapy. Int. J. Pharm. 303 1-2 (2005) 1-7
76. Fattal E., Couvreur P., and Dubernet C. "Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes. Adv. Drug Deliv. Rev. 56 7 (2004) 931-946
77. Hui H., Xiao-dong F., and Zhong-lin C. Thermo- and pH-sensitive dendrimer derivatives with a shell of poly(N,N-dimethylaminoethyl methacrylate) and study of their controlled drug release behavior. Polymer 46 22 (2005) 9514-9522
78. Lai P.S., Lou P.J., Peng C.L., Pai C.L., Yen W.N., Huang M.Y., Young T.H., and Shieh M.J. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy. J. Control. Release 122 1 (2007) 39-46
79. Devalapally H., Shenoy D., Little S., Langer R., and Amiji M. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model. Cancer Chemother. Pharmacol. 59 4 (2007) 477-484
80. Na K., Lee E.S., and Bae Y.H. Adriamycin loaded pullulan acetate/sulfonamide conjugate nanoparticles responding to tumor pH: pH-dependent cell interaction, internalization and cytotoxicity in vitro. J. Control. Release 87 1-3 (2003) 3-13
81. Murthy N., Campbell J., Fausto N., Hoffman A.S., and Stayton P.S. Design and synthesis of pH-responsive polymeric carriers that target uptake and enhance the intracellular delivery of oligonucleotides. J. Control. Release 89 (2003) 365-374
82. Bulmus V., Woodward M., Lin L., Murthy N., Stayton P.S., and Hoffman A. A new pH-responsive and glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs. J. Control. Release 93 (2003) 105-120
83. Stayton P.S., El-Sayed M.E., Murthy N., Bulmus V., Lackey C., Cheung C., and Hoffman A.S. 'Smart' delivery systems for biomolecular therapeutics. Orthod. Craniofac. Res. 8 (2005) 219-225
84. Kamada H., Tsutsumi Y., Yoshioka Y., Yamamoto Y., Kodaira H., Tsunoda S., Okamoto T., Mukai Y., Shibata H., Nakagawa S., and Mayumi T. Design of a pH-sensitive polymeric carrier for drug release and its application in cancer therapy. Clin. Cancer Res. 10 (2004) 2545-2550
85. Ulbrich K., Subr V., Strohalm J., Plocova D., Jelinkova M., and Rihova B. Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterisation. J. Control. Release 64 (2000) 63-79
86. Ulbrich K., Etrych T., Chytil P., Jelinkova M., and Rihova B. Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation. J. Drug Target 12 (2004) 477-489
87. Kratz F., Beyer U., Roth T., Tarasova N., Collery P., Lechenault F., Cazabat A., Schumacher P., Unger C., and Falken U. Transferrin conjugates of doxorubicin: synthesis, characterization, cellular uptake, and in vitro efficacy. J. Pharm. Sci. 87 (1998) 338-346
88. Beyer U., Roth T., Schumacher P., Maier G., Unold A., Frahm A.W., Fiebig H.H., Unger C., and Kratz F. Synthesis and in vitro efficacy of transferrin conjugates of the anticancer drug chlorambucil. J. Med. Chem. 41 (1998) 2701-2708
89. Drevs J., Hofmann I., Marme D., Unger C., and Kratz F. In vivo and in vitro efficacy of an acid-sensitive albumin conjugate of adriamycin compared to the parent compound in murine renal-cell carcinoma. Drug Deliv. 6 (1999) 89-95
90. Tomlinson R., Heller J., Brocchini S., and Duncan R. Polyacetal-doxorubicin conjugates designed for pH-dependent degradation. Bioconjug. Chem. 14 (2003) 1096-1106
91. Torchillin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev., Drug Discov. 4 (2005) 145-160
92. Papanicolaou I., Briggs S., and Alpar H.O. Increased resistance of DNA lipoplexes to protein binding in vitro by surface-modification with a multivalent hydrophilic polymer. J. Drug Target 12 8 (2004) 541-547
93. Simoes S., Moreira J.N., Fonseca C., Duzgunes N., and Lima M.C. On the formulation of pH-sensitive liposomes with long circulation times. Adv. Drug Deliv. Rev. 56 (2004) 947-965
94. Roux E., Passirani C., Scheffold S., Benoit J.P., and Leroux J.C. Serum-stable and long-circulating, PEGylated, pH-sensitive liposomes. J. Control. Release 94 (2004) 447-451
95. Kakudo T., Chaki S., Futaki S., Nakase I., Akaji K., Kawakami T., Maruyama K., Kamiya H., and Harashima H. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system. Biochemistry 43 (2004) 5618-5628
96. Wang C.Y., and Huang L. Highly efficient DNA delivery mediated by pH-sensitive immunoliposomes. Biochemistry 28 (1989) 9508-9514
97. Litzinger D.C., and Huang L. Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications. Biochim. Biophys. Acta 1113 (1992) 201-227
98. Connor J., and Huang L. pH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugs. Cancer Res. 46 (1986) 3431-3435
99. Couvreur P., Fattal E., Malvy C., and Dubernet C. pH-sensitive liposomes: an intelligent system for the delivery of antisense oligonucleotides. J. Liposome Res. 7 (1997) 1-18
100. Couffin-Hoarau A.C., and Leroux J.C. Report on the use of poly(organophosphazenes) for the design of stimuli-responsive vesicles. Biomacromolecules 5 (2004) 2082-2087
101. Leroux J., Roux E., Le Garrec D., Hong K., and Drummond D.C. N-isopropylacrylamide copolymers for the preparation of pH-sensitive liposomes and polymeric micelles. J. Control. Release 72 1-3 (2001) 71-84
102. Ellens H., Bentz J., and Szoka F.C. pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact. Biochemistry 23 (1984) 1532-1538
103. Lee R.J., Wang S., Turk M.J., and Low P.S. The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery. Biosci. Rep. 18 (1998) 69-78
104. Kataoka K., Harada A., and Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev. 47 1 (2001) 113-131
105. Kwon G.S., and Okano T. Polymeric micelles as new drug carriers. Adv. Drug Deliv. Rev. 21 (1996) 107-116
106. Gillies E.R., and Fréchet J.M.J. Development of acid sensitive copolymer micelles for drug delivery. Pure Appl. Chem. 76 (2004) 1295-1308
107. Shim W.S., Kim S.W., Choi E.K., Park H.J., Kim J.S., and Lee D.S. Novel pH sensitive block copolymer micelles for solvent free drug loading. Macromol. Biosci. 6 2 (2006) 179-186
108. Lee E.S., Shin H.J., Na K., and Bae Y.H. Poly(l-histidine)-PEG block copolymer micelles and pH-induced destabilization. J. Control. Release 90 3 (2003) 363-374
109. Low P.S., and Lee R.J. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochem. Biophys. Acta 1233 (1995) 134-144
110. Reddy J.A., and Low P.S. Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit. Rev. Ther. Drug Carrier Syst. 15 (1998) 587-627
111. Ross J.F., Chaudhuri P.K., and Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73 (1994) 2432-2443
112. Lee E.S., Na K., and Bae Y.H. Super pH-sensitive multifunctional polymeric micelle. Nano Lett. 5 2 (2005) 325-329
113. Shen H., and Eisenberg A. Control of architecture in block-copolymer vesicles. Angew. Chem., Int. Ed. (2000)
114. Liu S., and Armes S.P. Synthesis and aqueous solution behavior of a pH-responsive schizophrenic diblock copolymer. Langmuir 19 (2003) 4432-4438
115. Bütün V., Armes S.P., Billingham N.C., Tuzar Z., Rankin A., Eastoe J., and Heenan R.K. The remarkable "flip-flop" self-assembly of a diblock copolymer in aqueous solution. Macromolecular 34 (2001) 1503-1511
116. Heskins M., and Guillet J.E. Solution properties of poly(N-isopropylacrylamide. J. Macromol. Sci. Chem. A2 (1968) 1441-1455
117. Beltran S., Baker J.P., Hooper H.H., Blanch H.W., and Prausnitz J.M. Swelling equilibria for weakly ionizable, temperature-sensitive hydrogels. Macromolecular 24 (1991) 549-551
118. Hsiue G.H., Wang C.H., Lo C.L., Wang C.H., Li J.P., and Yang J.L. Environmental-sensitive micelles based on poly(2-ethyl-2-oxazoline)-b-poly(l-lactide) diblock copolymer for application in drug delivery. Int. J. Pharm. 317 1 (2006) 69-75
119. Taillefer J., Jones M.C., Brasseur N., van Lier J.E., and Leroux J.C. Preparation and characterization of pH-responsive polymeric micelles for the delivery of photosensitizing anticancer drugs. J. Pharm. Sci. 89 1 (2000) 52-62
120. Le Garrec D., Taillefer J., Van Lier J.E., Lenaerts V., and Leroux J.C. Optimizing pH-responsive polymeric micelles for drug delivery in a cancer photodynamic therapy model. J. Drug Target. 10 5 (2002) 429-437
121. McLennan I.J., Lenkinski R.E., and Yanuka Y. A nuclear magnetic resonance study of the self-association of adriamycin and daunomycin in aqueous solution. Can. J. Chem. 63 (1985) 1233-1238
122. Kataoka K., Matsumoto T., Yokoyama M., Okano T., Sakurai Y., Fukushima S., Okamoto K., and Kwon G.S. Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J. Control. Release 64 1-3 (2000) 143-153
123. Tomalia D.A., Baker H., Dewald J.R., Hall M., Kallos G., Martin S., Roeck J., Ryder J., and Smith P. A new class of polymers: starburst-dendritic macromolecules. Polym. J. (Tokyo) 17 (1985) 117-132
124. Esfand R., and Tomalia D.A. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov. Today 6 (2001) 427-436
125. Ihre H.R., Padilla O.L., Jesu D., Szoka J.F.C., and Frechet J.M.J. Polyester dendritic systems for drug delivery applications: design, synthesis, and characterization. Bioconju. Chem. 13 (2002) 443-452
126. Gillies E.R., Jonsson T.B., and Fréchet J.M.J. Stimuli-responsive supramolecular assemblies of linear-dendritic copolymers. J. Am. Chem. Soc. 126 (2004) 11936-11943
127. Na K., Lee K.H., Lee D.H., and Bae Y.H. Biodegradable thermo-sensitive nanoparticles from poly(l-lactic acid)/poly(ethylene glycol) alternating multi-block copolymer for potential anti-cancer drug carrier. Eur. J. Pharm. Sci. 27 2-3 (2006) 115-122
128. Chung J.E., Yokoyama M., Yamato M., Aoyagi T., Sakurai Y., and Okano T. Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate). J. Control. Release 62 1-2 (1999) 115-127
129. Kong G., Anyarambhatla G., Petros W.P., Braun R.D., Colvin O.M., Needham D., and Dewhirst M.W. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res. 60 24 (2000) 6950-6957
130. Hayashi H., Kono K., and Takagishi T. Temperature-controlled release property of phospholipid vesicles bearing a thermo-sensitive polymer. Biochim. Biophys. Acta 1280 (1996) 127-134
131. Wells J., Sen A., and Hui S.W. Localized delivery to CT-26 tumors in mice using thermosensitive liposomes. Int. J. Pharm. 261 1-2 (2003) 105-114
132. Kale A.A., and Torchilin V.P. Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified PEGylated liposomes. J. Drug Target. 15 (2007) 538-545
133. Cavallaro G., Campisi M., Licciardi M., Ogris M., and Giammona G. Reversibly stable thiopolyplexes for intracellular delivery of genes. J. Control. Release 115 3 (2006) 322-334
134. Balakirev M., Schoehn G., and Chroboczek J. Lipoic acid-derived amphiphiles for redox-controlled DNA delivery. Chem. Biol. 7 (2000) 813-819
135. Anderson W.R., Simpkins J.W., Brewster M.E., and Bodor N. Evidence for suppression of serum LH without elevation in serum estradiol or prolactin with a brain-enhanced redox delivery system for estradiol. Life Sci. 42 (1988) 1493-1502
136. Rijcken C.J.F., Soga O., Hennink W.E., and Nostrum C.F.V. Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery. J. Control. Release 120 3 (2007) 131-148
137. Yoshida R., Uchida K., Kaneko Y., Sakai K., Kikuchi A., Sakurai Y., and Okano T. Comb-type grafted hydrogels with rapid deswelling response to temperature changes. Nature 374 (1995) 240-242
138. Kim S.Y., Ha J.C., and Lee Y.M. Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres. II. Thermo-responsive drug release behaviors. J. Control. Release 65 (2000) 345-358
139. Bae K.H., Choi S.H., Park S.Y., Lee Y., and Park T.G. Thermosensitive pluronic micelles stabilized by shell cross-linking with gold nanoparticles. Langmuir 22 (2006) 6380-6634
140. Molineux G. PEGylation: engineering improved pharmaceuticals for enhanced therapy. Cancer Treat. Rev. 28 (2002) 13-16
141. Chung J.E., Yokoyama M., and Okano T. Inner core segment design for drug delivery control of thermo-responsive polymeric micelles. J. Control. Release 65 (2000) 93-103
142. Yokoyama M. Gene delivery using temperature responsive polymeric carriers. Drug Discov. Today 7 (2002) 426-432
143. Liu X.M., Yang Y.Y., and Leong K.W. Thermally responsive polymeric micellar nanoparticles self-assembled from cholesteryl end-capped random poly (N-isopropylacrylamide-co-N,N-dimethylacrylamide): synthesis, temperature-sensitivity, and morphologies. J. Colloid Interface Sci. 266 (2003) 295-303
144. Turk M., Dincer S., Yulug I.G., and Piskin E. In vitro transfection of HeLa cells with temperature sensitive polycationic copolymers. J. Control. Release 96 2 (2004) 325-340
145. Türk M., Dinçer S., and Piskin E. Smart and cationic poly(NIPA)/PEI block copolymers as non-viral vectors: in vitro and in vivo transfection studies. J. Tissue Eng. Regen. Med. 1 5 (2007) 377-388
146. Piskin E., Dincer S., and Turk M. Gene delivery: intelligent but just at the beginning. J. Biomater. Sci. 15 9 (2004) 1181-1202
147. Dincer S., Turk M., and Piskin E. Intelligent polymers as nonviral vectors. Gene Ther. 12 S1 (2005) S139-S145
148. Piskin E. Stimuli-responsive polymers in gene delivery. Expert Rev. Med. Devices 2 (2005) 501-509
149. Twaites B.R., de las Heras Alarcon C., Cunliffe D., Lavigne M., Pennadam S., Smith J.R., Gorecki D.C., and Alexander C. Thermo and pH responsive polymers as gene delivery vectors: effect of polymer architecture on DNA complexation in vitro. J. Control. Release 97 3 (2004) 551-566
150. Twaites B.R., de las Heras Alarcon C., Lavigne M., Saulnier A., Pennadam S.S., Cunliffe D., Gorecki D.C., and Alexander C. Thermoresponsive polymers as gene delivery vectors: cell viability, DNA transport and transfection studies. J. Control. Release 108 2-3 (2005) 472-483
151. Yatvin M.B., Weinstein J.N., Dennis W.H., and Blumenthal R. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 202 (1978) 1290-1293
152. Kono K. Thermosensitive polymer-modified liposomes. Adv. Drug Deliv. Rev. 53 3 (2001) 307-319
153. Schild H.G. Poly(N-isopropylacrylamide): experiment, theory and application. Prog. Polym. Sci. 17 2 (1992) 163-249
154. Kono K., Nakai R., Morimoto K., and Takagishi T. Thermosensitive polymer-modified liposomes that release contents around physiological temperature. Biochim. Biophys. Acta 1416 1-2 (1999) 239-250
155. Kono K., Nakai R., Morimoto K., and Takagishi T. Temperature-dependent interaction of thermo-sensitive polymer-modified liposomes with CV1 cells. FEBS Lett. 456 2 (1999) 306-310
156. Kono K., Yoshino K., and Takagishi T. Effect of poly(ethylene glycol) grafts on temperature-sensitivity of thermosensitive polymer-modified liposomes. J. Control. Release 80 1-3 (2002) 321-332
157. Han H.D., Shin B.C., and Choi H.S. Doxorubicin-encapsulated thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-acrylamide): drug release behavior and stability in the presence of serum. Eur. J. Pharm. Biopharm. 62 (2006) 110-116
158. Chandaroy P., Sen A., and Hui S.W. Temperature-controlled content release from liposomes encapsulating Pluronic F127. J. Control. Release 76 (2001) 27-37
159. Ward C.M., Read M.L., and Seymour L.W. Systemic circulation of poly (l-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. Blood 97 (2001) 2221-2229
160. Kwoh D.Y., Coffin C.C., Lollo C.P., Jovena J., and Banaszczyk M.G. Stabilization of poly-l-lysine/DNA polyplexes for in vivo gene delivery to the liver. Biochim. Biophys. Acta 1444 (1999) 171-190
161. Niculescu D.I. Technology evaluation: gemtuzumab ozogamicin, Celltech Group. Curr. Opin. Mol. Ther. 2 (2000) 691-696
162. Carlisle R.C., Etrych T., Briggs S.S., Preece J.A., Ulbrich K., and Seymour L.W. Polymer-coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction. J. Gene Med. 6 (2004) 337-344
163. Wang Y., Chen P., and Shen J. The development and characterization of a glutathione-sensitive cross-linked polyethylenimine gene vector. Biomaterials 27 (2006) 5292-5298
164. Schmitz T., Bravo O.I., Vauthier C., Ponchel G., Loretz B., and Bernkop S.A. Development and in vitro evaluation of a thiomer-based nanoparticulate gene delivery system. Biomaterials 28 (2007) 524-531
165. Kevin R.W., and Otto S. Reversible covalent chemistry in drug delivery. Cur. Drug Discov. Tech. 2 (2005) 123-160
166. Zhaohua H., Weijun L., Andrew MacKay J., Francis J., and Szoka C. Thiocholesterol-based lipids for ordered assembly of bioresponsive gene carriers. Mol. Ther. 11 (2005) 409-417
167. Kirpotin D., Hong K.L., Mullah N., Papahadjopoulos D., and Zalipsky S. Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface-grafted poly(ethylene glycol). FEBS Lett. 388 (1996) 115
168. Gabizon A.A., Tzemach D., Horowitz A.T., Shmeeda H., Yeh J., and Zalipsky S. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in PEGylated liposomes. Clin. Cancer Res. 12 (2006) 1913-1920